MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10840-026-02410-x

Медицинская библиотека · Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026

From trial to practice: early multicenter real-world experience with the circular pulsed field ablation catheter.

Ballesteros Gabriel, Barrera Alberto, Pérez Castellano Nicasio, Mazuelos Bellido Francisco, Fernández-Ruz Leopoldo, Bertelli Germán, Calvo Cuervo David, Gutiérrez Ballesteros Guillermo, González-Lozano Jaime, Muñiz Javier, Cruz Galbán Alba, Ruiz Amalio, Burgos-Martín Antonia, Segura José María

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The PulseSelect™ circular pulsed field ablation (PFA) catheter demonstrated excellent safety in its pivotal trial, but real-world evidence on its early adoption and implementation remains scarce.

OBJECTIVE

To report the first multicentre, real-world experience of atrial fibrillation (AF) ablation with the PulseSelect circular PFA catheter, focusing on procedural characteristics, metrics, safety and short-term clinical outcomes.

METHODS

This observational study included the first 520 consecutive patients undergoing AF ablation with the PulseSelect catheter across five Spanish centres. Patient and procedural characteristics, safety (major complications), acute pulmonary vein isolation (PVI) rate and arrhythmia recurrence during follow-up were recorded.

RESULTS

Acute PVI was achieved in 518/520 patients (99.6%). Procedures were performed under deep sedation (52.7%) or general anaesthesia (47.3%), without anaesthesia-related complications. Mean procedural time was 69.95 min, with a learning curve plateauing after the first 8-10 cases. Same-day or < 24 h discharge occurred in 95.4%. Major complications occurred in four patients (0.76%); no deaths or clinically evident haemolysis were observed. Electroanatomical mapping (EAM) was used in a minority of cases (3.65%); when used, there was 100% concordance between post-ablation maps and PulseSelect catheter recordings in confirming PVI. During a mean follow-up of 10.8 ± 5 months, arrhythmia recurrence after the 3-month blanking period occurred in 16.2% of patients. After one year of follow-up, arrhythmic recurrence was observed in 52/220 (23.63%) patients.

CONCLUSIONS

In the first large real-world series, AF ablation with the PulseSelect circular PFA catheter without routine use of EAM was feasible, safe, and effective, with major complications < 1% and short hospitalisation. These findings support rapid and safe implementation of this technology in clinical practice, with flexibility regarding anaesthesia modality.

Для цитирования: Ballesteros Gabriel, Barrera Alberto, Pérez Castellano Nicasio, Mazuelos Bellido Francisco, Fernández-Ruz Leopoldo, Bertelli Germán, Calvo Cuervo David, Gutiérrez Ballesteros Guillermo, González-Lozano Jaime, Muñiz Javier, Cruz Galbán Alba, Ruiz Amalio, Burgos-Martín Antonia, Segura José María. From trial to practice: early multicenter real-world experience with the circular pulsed field ablation catheter.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2026. DOI: 10.1007/s10840-026-02410-x.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.